NovaGo Therapeutics
NovaGo Therapeutics is a development stage biotech company focused on human antibody therapeutics for spinal cord injury.
1
Funding Rounds
$10.0m
Money raised
Overview
NovaGo Therapeutics is a development stage biotech company focused on human antibody therapeutics for spinal cord injury.
- Website:
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company NovaGo Therapeutics has raised a total of $10m in funding over 1 rounds.
Key Insights:
- NovaGo Therapeutics Series A round, March 2019: $10m
NovaGo Therapeutics Series A round, March 2019
$10m
Industries
NovaGo Therapeutics is active in the following industries: